Although the significance of GSK-3 in the pathology of bipolar disorder is still debated (Alda, 2015), these observations suggest that dysregulation of GSK-3 could, at least in part, account for the bipolar disorder-related behaviors induced by hypoactive TRPM2 mutations. Here, TRPM2 is linked to bipolar disorder.